Treatment with Bendamustine-Bortezomib-Dexamethasone (BBD) in Relapsed/Refractory Multiple Myeloma Shows Significant Activity and Is Well Tolerated.

H Ludwig; H Kasparu; R Greil; C Leitgeb; E Muldur; E Rauch; N Zojer; EM Autzinger; Werner Linkesch; T Kuhr; L Pour; Z Adam

Treatment with Bendamustine-Bortezomib-Dexamethasone (BBD) in Relapsed/Refractory Multiple Myeloma Shows Significant Activity and Is Well Tolerated.

H Ludwig
, H Kasparu
, R Greil
, C Leitgeb
, E Muldur
, E Rauch
, N Zojer
, EM Autzinger
, Werner Linkesch
, T Kuhr
, L Pour
, Z Adam

Division of Haematology

Research output: Contribution to journal › Conference abstract

Original language	English
Journal	Blood
Publication status	Published - 2012
Event	54th Annual Meeting of the American Society of Hematology - Atlanta, United States Duration: 8 Dec 2012 → 11 Dec 2012

Branches of science

302 Clinical Medicine

Links

Web of Science

Treatment with Bendamustine-Bortezomib-Dexamethasone (BBD) in Relapsed/Refractory Multiple Myeloma Shows Significant Activity and Is Well Tolerated.
Ludwig, H. (Author), Kasparu, H. (Author), Greil, R. (Author), Leitgeb, C. (Author), Muldur, E. (Author), Rauch, E. (Author), Zojer, N. (Author), Autzinger, E. (Author), Linkesch, W. (Author), Kuhr, T. (Author), Pour, L. (Author) & Adam, Z. (Author)
2012
Activity: Talk, presentation or poster › Poster

Cite this

@article{6e6ec63fa01e4dd98bf3807842db3bba,

title = "Treatment with Bendamustine-Bortezomib-Dexamethasone (BBD) in Relapsed/Refractory Multiple Myeloma Shows Significant Activity and Is Well Tolerated.",

author = "H Ludwig and H Kasparu and R Greil and C Leitgeb and E Muldur and E Rauch and N Zojer and EM Autzinger and Werner Linkesch and T Kuhr and L Pour and Z Adam",

year = "2012",

language = "English",

journal = "Blood",

issn = "0006-4971",

publisher = "Elsevier B.V.",

note = "54th Annual Meeting of the American Society of Hematology, ASH 54 ; Conference date: 08-12-2012 Through 11-12-2012",

}

TY - JOUR

T1 - Treatment with Bendamustine-Bortezomib-Dexamethasone (BBD) in Relapsed/Refractory Multiple Myeloma Shows Significant Activity and Is Well Tolerated.

AU - Ludwig, H

AU - Kasparu, H

AU - Greil, R

AU - Leitgeb, C

AU - Muldur, E

AU - Rauch, E

AU - Zojer, N

AU - Autzinger, EM

AU - Linkesch, Werner

AU - Kuhr, T

AU - Pour, L

AU - Adam, Z

PY - 2012

Y1 - 2012

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:000313838901194

M3 - Conference abstract

SN - 0006-4971

JO - Blood

JF - Blood

T2 - 54th Annual Meeting of the American Society of Hematology

Y2 - 8 December 2012 through 11 December 2012

ER -

Treatment with Bendamustine-Bortezomib-Dexamethasone (BBD) in Relapsed/Refractory Multiple Myeloma Shows Significant Activity and Is Well Tolerated.

Branches of science

Links

Activities

Treatment with Bendamustine-Bortezomib-Dexamethasone (BBD) in Relapsed/Refractory Multiple Myeloma Shows Significant Activity and Is Well Tolerated.

Cite this